tetano
Editor, Senior Moderator
ACS Appl Bio Mater
. 2021 Jun 21;4(6):4953-4961.
doi: 10.1021/acsabm.1c00240. Epub 2021 May 11.
Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses
Ye Wang[SUP] 1 [/SUP], Song Li[SUP] 2 [/SUP], Chunhong Dong[SUP] 1 [/SUP], Yao Ma[SUP] 1 [/SUP], Yufeng Song[SUP] 1 [/SUP], Wandi Zhu[SUP] 1 [/SUP], Joo Kim[SUP] 1 [/SUP], Lei Deng[SUP] 1 [/SUP], Timothy L Denning[SUP] 1 [/SUP], Sang-Moo Kang[SUP] 1 [/SUP], Mark R Prausnitz[SUP] 2 [/SUP], Bao-Zhong Wang[SUP] 1 [/SUP]
Affiliations
Abstract
We generated self-adjuvanted protein nanoparticles of conserved influenza antigens and immunized mice via skin vaccination with dissolvable microneedle patches (MNPs) to increase the strength and breadth of immune responses. We produced M2e nanoparticles via ethanol desolvation, and double-layered NA1/M2e (shell/core), NA1-FliC/M2e, NA2/M2e, and NA2-FliC/M2e protein nanoparticles by chemically crosslinking influenza NA and flagellin (FliC) onto the surfaces of the M2e nanoparticles. The resulting nanoparticles retained FliC TLR5 innate signaling activity and significantly increased antigen-uptake and dendritic cell maturation in vitro. We incorporated the nanoparticles into MNPs for skin vaccination in mice. The nanoparticle MNPs significantly increased M2e and NA-specific antibody levels, the numbers of germinal center B cells, and IL-4 positive splenocytes. Double-layered nanoparticle MNP skin vaccination protected mice against homologous and heterosubtypic influenza viruses. Our results demonstrated that MNP skin vaccination of NA-FliC/M2e nanoparticles could be developed into a standalone or synergistic component of a universal influenza vaccine strategy.
Keywords: Dissolvable microneedle patch; Flagellin adjuvant; Influenza NA protein nanoparticle; Skin vaccination; Universal influenza vaccine.
. 2021 Jun 21;4(6):4953-4961.
doi: 10.1021/acsabm.1c00240. Epub 2021 May 11.
Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses
Ye Wang[SUP] 1 [/SUP], Song Li[SUP] 2 [/SUP], Chunhong Dong[SUP] 1 [/SUP], Yao Ma[SUP] 1 [/SUP], Yufeng Song[SUP] 1 [/SUP], Wandi Zhu[SUP] 1 [/SUP], Joo Kim[SUP] 1 [/SUP], Lei Deng[SUP] 1 [/SUP], Timothy L Denning[SUP] 1 [/SUP], Sang-Moo Kang[SUP] 1 [/SUP], Mark R Prausnitz[SUP] 2 [/SUP], Bao-Zhong Wang[SUP] 1 [/SUP]
Affiliations
- PMID: 34179728
- PMCID: PMC8232372
- DOI: 10.1021/acsabm.1c00240
Abstract
We generated self-adjuvanted protein nanoparticles of conserved influenza antigens and immunized mice via skin vaccination with dissolvable microneedle patches (MNPs) to increase the strength and breadth of immune responses. We produced M2e nanoparticles via ethanol desolvation, and double-layered NA1/M2e (shell/core), NA1-FliC/M2e, NA2/M2e, and NA2-FliC/M2e protein nanoparticles by chemically crosslinking influenza NA and flagellin (FliC) onto the surfaces of the M2e nanoparticles. The resulting nanoparticles retained FliC TLR5 innate signaling activity and significantly increased antigen-uptake and dendritic cell maturation in vitro. We incorporated the nanoparticles into MNPs for skin vaccination in mice. The nanoparticle MNPs significantly increased M2e and NA-specific antibody levels, the numbers of germinal center B cells, and IL-4 positive splenocytes. Double-layered nanoparticle MNP skin vaccination protected mice against homologous and heterosubtypic influenza viruses. Our results demonstrated that MNP skin vaccination of NA-FliC/M2e nanoparticles could be developed into a standalone or synergistic component of a universal influenza vaccine strategy.
Keywords: Dissolvable microneedle patch; Flagellin adjuvant; Influenza NA protein nanoparticle; Skin vaccination; Universal influenza vaccine.